FDA Submission For Abbreviated New Drug Application $750 Million Market For Suicidal Depression Market Awaits Preservative-Free IV Ketamine: Nrx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Home - Spotlight - FDA Submission For Abbreviated New Drug Application $750 Million Market For Suicidal Depression Market Awaits Preservative-Free IV Ketamine: Nrx Pharmaceuticals, Inc. (Nasdaq: NRXP)
(MENAFN – GetNews) $NRXP Given a $34 Price Target in D. Boral Analyst Report Developing NRX-101, an FDA-Designated Investigational Breakthrough Therapy for Suicidal Treatment-Resistant Bipolar …
